ATE521895T1 - Verfahren zum interpretieren von tandem- massenspektrometerdaten zur klinischen diagnose - Google Patents

Verfahren zum interpretieren von tandem- massenspektrometerdaten zur klinischen diagnose

Info

Publication number
ATE521895T1
ATE521895T1 AT00986356T AT00986356T ATE521895T1 AT E521895 T1 ATE521895 T1 AT E521895T1 AT 00986356 T AT00986356 T AT 00986356T AT 00986356 T AT00986356 T AT 00986356T AT E521895 T1 ATE521895 T1 AT E521895T1
Authority
AT
Austria
Prior art keywords
mass spectrometer
tandem mass
clinical diagnosis
spectrometer data
data
Prior art date
Application number
AT00986356T
Other languages
English (en)
Inventor
Donald Chace
Original Assignee
Perkinelmer Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perkinelmer Genetics Inc filed Critical Perkinelmer Genetics Inc
Application granted granted Critical
Publication of ATE521895T1 publication Critical patent/ATE521895T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00986356T 2000-12-12 2000-12-12 Verfahren zum interpretieren von tandem- massenspektrometerdaten zur klinischen diagnose ATE521895T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/033790 WO2002048697A1 (en) 2000-12-12 2000-12-12 Method for interpreting tandem mass spectrometry data for clinical diagnosis

Publications (1)

Publication Number Publication Date
ATE521895T1 true ATE521895T1 (de) 2011-09-15

Family

ID=21742065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00986356T ATE521895T1 (de) 2000-12-12 2000-12-12 Verfahren zum interpretieren von tandem- massenspektrometerdaten zur klinischen diagnose

Country Status (7)

Country Link
EP (1) EP1412727B1 (de)
KR (1) KR100572619B1 (de)
AT (1) ATE521895T1 (de)
AU (2) AU2260901A (de)
BR (1) BR0017383A (de)
MX (1) MXPA03005021A (de)
WO (1) WO2002048697A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080102535A1 (en) * 2006-11-01 2008-05-01 Chace Donald H Measuring thyroxine levels from dried blood samples using mass spectrometry
KR101034900B1 (ko) * 2010-05-26 2011-05-17 정구조안전진단(주) 어스앵커용 3d 브라켓
KR102574098B1 (ko) 2022-06-07 2023-09-01 (재)씨젠의료재단 신생아의 선천성 대사 이상 검사에 대한 소견 생성 자료 제공 방법 및 장치
KR102574100B1 (ko) 2022-06-07 2023-09-01 (재)씨젠의료재단 신생아의 선천성 대사 이상 검사에 대한 소견 생성 자료 제공 시스템

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5365426A (en) * 1987-03-13 1994-11-15 The University Of Maryland Advanced signal processing methodology for the detection, localization and quantification of acute myocardial ischemia
US5251126A (en) * 1990-10-29 1993-10-05 Miles Inc. Diabetes data analysis and interpretation method
US5072115A (en) * 1990-12-14 1991-12-10 Finnigan Corporation Interpretation of mass spectra of multiply charged ions of mixtures
US5878746A (en) * 1993-08-25 1999-03-09 Lemelson; Jerome H. Computerized medical diagnostic system
US5453613A (en) * 1994-10-21 1995-09-26 Hewlett Packard Company Mass spectra interpretation system including spectra extraction
US5545895A (en) * 1995-03-20 1996-08-13 The Dow Chemical Company Method of standardizing data obtained through mass spectrometry

Also Published As

Publication number Publication date
EP1412727A4 (de) 2004-12-29
EP1412727A1 (de) 2004-04-28
EP1412727B1 (de) 2011-08-24
WO2002048697A1 (en) 2002-06-20
KR20030072358A (ko) 2003-09-13
AU2001222609B2 (en) 2006-04-13
MXPA03005021A (es) 2004-09-10
BR0017383A (pt) 2004-02-03
KR100572619B1 (ko) 2006-04-24
AU2260901A (en) 2002-06-24

Similar Documents

Publication Publication Date Title
DE60041355D1 (de) Verfahren zur detektion von erkrankungen
DE60042695D1 (de) Verfahren für den nachweis von erkrankungen
EP0933707A3 (de) Verschiebbare Instrumentationskennzeichen für die Prüfung und Fehlerbeseitigung eines Computerprogramms
DE60124541D1 (de) Verfahren und vorrichtung zur darstellung von information die durch elektrische impedanz-tomografie erhalten ist
DE60234258D1 (de) Verfahren und vorrichtung zur frühdiagnose von subakuten, aber möglicherweise tödlichen krankheiten
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DE69811832D1 (de) Verfahren zur Schätzung von Statistiken der Eigenschaften von durch eine Prozessorpipeline bearbeiteten Wechselwirkungen
ATE440151T1 (de) Verfahren zur beurteilung eines krankheitzustandes mittels nachweis von partikel- und nicht partikelgebundenen nukleinsäuren in blutplasma und -serum
DE69429999D1 (de) Verfahren zur herstellung von diagnostischen reagentien, testverfahren und medikamenten, die auf den klinischen manifestationen einer krankheit beruhen
ATE98773T1 (de) Verfahren zur optischen analyse.
DE3887168D1 (de) Verfahren zur quantitativen analyse von mineralien.
ATE275642T1 (de) Verfahren zur diagnose von krebs
ATE270449T1 (de) Verfahren und rechnerprogramm zur bildanalyse
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
DE3482594D1 (de) Analytische testzusammensetzung, vorrichtung, verfahren zu ihrer herstellung und zur bestimmung von peroxidatisch wirkenden substanzen.
DE69022425D1 (de) Verfahren zur Bestimmung der funktionellen Wirkung von freiem Protein S oder Protein C in einer Plasmaprobe.
ATE431428T1 (de) Ein verfahren zur analyse von polynukleotiden
ATE521895T1 (de) Verfahren zum interpretieren von tandem- massenspektrometerdaten zur klinischen diagnose
ATE532072T1 (de) Verfahren und vorrichtung zur beurteilung von polypeptidaggregation
ATE462001T1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
DE3482680D1 (de) Verfahren zur analyse von aminosaeuren.
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
DE50105263D1 (de) Verfahren zur analyse von proteinen
DE69927691D1 (de) Verfahren zur eiweissanalyse
DE69711073D1 (de) Verfahren zur erkennung von lebenden mikrobiologischen verunreinigungen in einer lebensmittelprobe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties